In vivo exposure to sodium fluoride does not modify the yield of viral tumour-induced periosteal bone nor of heterotopic bone induced by human tumour KB cells in mice.
In mice local or systemic administration of fluoride (5-25 mg NaF/kg body weight) during the proliferative phase of bone formation (up to 20 days) has no effect on the yield of bone formed either by local stimulation of periosteal membrane by Moloney sarcoma virus-induced tumour or on bone induced heterotopically by human KB cells. The lack of stimulatory activity of fluoride on rapidly induced osteogenesis in mice is in agreement with recent reports which show that fluoride is not a potent mitogen for human osteoblasts grown in vitro.
Włodarski
P K
PK
Department of Histology, Institute of Biostructure, Medical School, Warsaw, Poland.
Włodarski
K H
KH
Galus
K
K
Skarpetowski
A C
AC
Kowalski
M
M
Luczak
M
M
Marciniak
M M
MM
D000818:Animals; D001859:Bone Neoplasms / Q000473:pathology; D001842:Bone and Bones / Q000187:drug effects*; D002472:Cell Transformation, Viral; D005260:Female; D006801:Humans; D007624:KB Cells; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D008980:Moloney murine sarcoma virus; D009368:Neoplasm Transplantation; D010012:Osteogenesis / Q000187:drug effects*; D010521:Periosteum / Q000187:drug effects*; D012513:Sarcoma, Experimental / Q000378:metabolism; D012969:Sodium Fluoride / Q000008:administration & dosage / Q000494:pharmacology*
D012969:Sodium Fluoride